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Background/Objectives:Atrial ﬁbrillation (AF) is themost common type of cardiac arrhyth-
mia with patients dying frequently of stroke. In view of the unclear etiologies of AF and
a potential role of oxidative stress, the present study examined cardiac reactive oxygen
species production and NADPH oxidase (NOX) expression in AF patients. Methods and
Results: Patients with AF were older than those without (58.8± 11.7 vs. 47.8± 19.2,
p = 0.047). Whereas total O•−2 production (determined by electron spin resonance) was
similar in patients with and without AF, H2O2 production was more than doubled in AF
patients (149.8± 26.28 vs. 66.9± 7.14 pmol/mg/min, p = 0.0055), which correlated well
with a doubling in NOX isoform 4 (NOX4) expression. AF patients with co-existing hyper-
tension had three-fold higher H2O2 production compared to those without (239.0± 125.1
vs. 83.6± 51.3 pmol/mg/min, p = 0.003). Treatment of HL-1 atrial cells with angiotensin II,
a known modulator of atrial structural remodeling, resulted in upregulation of NOX4 and
H2O2 production, further implicating a potential role of NOX4 in atrial remodeling. Con-
clusion: Our data represent the ﬁrst implication that NOX4-derived H2O2 may play an
important role in the etiologies of AF.
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INTRODUCTION
Atrial ﬁbrillation (AF) is the most common type of cardiac
arrhythmia that is rapidly developing into an epidemic (Savelieva
and Camm, 2008). It is associated with markedly increased risk of
stroke,due to dislocation of thrombi that aremost often originated
from left atrial appendage (LAA).AlthoughAF is clearly associated
with aging, and cardiovascular conditions such as hypertension,
mitral valve stenosis, and heart failure, molecular mechanisms
underlying its etiology have remained elusive. Recent advances
seem to suggest thatAF is initiatedby atrial structural and electrical
remodeling, and that AF itself further augments these responses
to perpetuate AF (Savelieva and Camm, 2008; Chou and Chen,
2009).
The known risk factors for AF have all been linked to oxida-
tive stress, and inﬂammatory factors such as angiotensin II (Ang II)
(Kannel et al., 1998;Nakashima et al., 2000; Kim et al., 2003, 2005).
Ang II is a major vasoconstrictive hormone and its production is
elevated in patients with hypertension. It is also involved inmodu-
lating cardiac hypertrophy and remodeling. Of note, hypertension
is considered themost prevalent risk factor forAF.Atrial structural
remodeling can be induced by Ang II, resulting in atrial ﬁbrosis
andpossibly initiationof AF (Zografos andKatritsis, 2010;Tan and
Zimetbaum, 2011). A meta-analysis of 7 clinical trials involving a
total of 24,849 patients receivingACEIs and/orARBs for treatment
of hypertension, ischemic heart disease, heart failure, or diabetes
mellitus demonstrated that ACEIs/ARBs signiﬁcantly reduces the
risk of AF or its recurrence by 28% (Healey et al., 2005). Impor-
tantly, Ang II is an extremely potent activator of NADPH oxidase
(NOX) in the vascular cells (Cai et al., 2003; Choi et al., 2008;
Lassegue and Griendling, 2010). NOX-dependent reactive oxygen
species (ROS) production leads to nitric oxide (NO•) inactivation
and endothelial dysfunction, which underlie pathogenesis of vas-
cular diseases such as hypertension and atherosclerosis (Cai and
Harrison, 2000; Cai et al., 2003; Cai, 2005a,b). We hypothesize
that NOX-derived ROS might be important in mediating Ang II-
dependent development of AF. Some interesting data exist to show
that hydrogen peroxide increases Kv1.5 current amplitude at volt-
ages corresponding to the action potential repolarization phase
and accelerate Kv1.5 channel opening. These changes can reduce
the action potential duration, leading to a shortening of the atrial
effective refractory period (Caouette et al., 2003)
To test this hypothesis in human AF, cardiac tissues from
heart transplant patients were examined for ROS production and
expression of NOX isoforms. Interestingly, we found a speciﬁc
upregulation of NOX4 that was correlatedwithH2O2 overproduc-
tion inAF patients. None of the otherNOX isoformswere however
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regulated in AF. AF patients with co-existing hypertension had
more than 3-fold increase in H2O2 production compared to those
without. In atrial HL-1 cells,Ang II treatment led to increasedAT1
receptor expression, upregulation of NOX4 and increased H2O2
production. These human and cell culture data together impli-
cate that there might be a novel role of NOX4-derived H2O2 in
mediating Ang II-dependent AF development.
MATERIALS AND METHODS
PATIENT POPULATION
Left atrial appendage tissues isolated from randomly recruited
patients undergoing cardiac transplant surgeries were subjected
to electron spin resonance (ESR) determination of O•−2 produc-
tion,Amplex red determination of H2O2 production and RT-PCR
analysis of NOX gene expression. The study was carried out in a
double-blinded fashion. Clinical information was gathered upon
completion of laboratory analyses. IRB approval was obtained for
these studies.
ELECTRON SPIN RESONANCE DETECTION OF SUPEROXIDE RADICAL
The speciﬁc O•−2 spin trap CMH (0.5mmol/L; Noxygen) solution
was prepared freshly in nitrogen gas bubbled Krebs/HEPES buffer
containing diethyldithiocarbamic acid (DETC; 5μmol/l; Sigma)
and deferoxamine (25μmol/l; Sigma). The LAA homogenates
(in 50mmol/L Tris–HCl, pH 7.4, 0.1mmol/L EDTA, 0.1mmol/L
EGTA, and 1% (v/v) of protease inhibitor cocktail from Sigma)
were then mixed with the spin trap solution and loaded into glass
capillary (Fisher Scientiﬁc) for analysis of O•−2 production using
ESR spectrometer (Bruker), following a similar procedure as we
previously published for cultured endothelial cells (Chalupsky and
Cai, 2005; Gao et al., 2009a,b) intact mouse aortas (Chalupsky
and Cai, 2005; Oak and Cai, 2007; Gao et al., 2009a), and tis-
sue homogenates (Lu et al., 2009). The ESR settings used were as
follows: bio-ﬁeld 3,410, ﬁeld sweep 100G, microwave frequency
9.73GHz, microwave power 13.26mW, modulation amplitude
9.82G and 512 points of resolution.
AMPLEX-RED ASSAY OF HYDROGEN PEROXIDE PRODUCTION
The LAA lysates [in 20mmol/L Tris–HCl, pH 7.4, 150mmol/L
NaCl, 1mmol/L EGTA, 1mmol/L EDTA, 1% (v/v) Triton X-100,
2.5mmol/L sodiumpyrophosphate, 1mmol/LNa3VO4, 1mmol/L
β-glycerolphosphate, 1mmol/L PMSF, 1% (v/v) of protease
inhibitor cocktail fromSigma]were analyzed forH2O2 production
using a ﬂuorometric horseradish peroxidase assay (Amplex-Red
assay; Molecular Probes). Fluorescence was measured (excitation
530 nm and emission 590 nm) after 1 h of incubation at 37˚C in
the dark against background ﬂuorescence of buffer. Polyethylene
glycol-conjugated catalase (500U/ml, Sigma) inhibitable fraction
reﬂects speciﬁc H2O2 signal. The rate of H2O2 production was
presented as picomoles per milligram protein per minute after
calculation, according to a standard curve generated using fresh
H2O2 in reaction buffer.
RT-PCR ANALYSIS OF NOX mRNA EXPRESSION
Total RNA was extracted from the LAA using TRIzol (Invitrogen)
according to the manufacturer’s instructions. Reverse transcrip-
tion was performed in standard fashion with iScript cDNA syn-
thesis Kit (Bio-Rad). The primer sequences used for PCR reactions
are summarized in Table 1. The PCRs were carried out using an
iCycler (Bio-Rad) with the protocol of [(95˚C/2min) (95˚C/25 s,
57˚C/5 s, 68˚C 5min)× 35 (72˚C/10min)]. The PCR mix con-
tained GAPDH primers to generate GAPDH amplicon that served
as an internal control.
HL-1 CELL CULTURE AND STIMULATION BY ANG II
The HL-1 cells were obtained as generous gifts from Dr. William
Claycomb from Louisiana State University that have been exten-
sively characterized to maintain its differentiated cardiac pheno-
type using microscopic, genetic, immunohistochemical, electro-
physiological, and pharmacological techniques (Claycomb et al.,
1998; White et al., 2004). These beating cells were cultured fol-
lowing exact protocols as established by the Claycomb group
and found to keep their phenotype during the 24 h exposure
period to Ang II. The conﬂuent cells were kept quiescent in
media containing 0.01% FBS overnight and then stimulated with
Ang II (100 nmol/L) for 24 h prior to analysis of NOX4 protein
expression by Western blot (primary antibody from Abcam) and
H2O2 production by Amplex Red assay. NOX4 mRNA expres-
sion from identically treated cells was determined by real-time
RT-PCR.
STATISTICAL ANALYSIS
All data are presented as mean± SEM. Differences in O•−2 pro-
duction, H2O2 production, and mRNA expression of different
NOX isoforms between AF and non-AF groups were compared
using t tests. ANCOVA were performed to examine the correla-
tion between H2O2 and NOX4 mRNA expression in patients with
and without AF. Statistical signiﬁcance was set as p< 0.05.
RESULTS
PATIENT CHARACTERISTICS
Patient characteristics are summarized in Table 2. Eighteen
patients with AF were older than those without (n = 17;
p = 0.047). The gender distributionwas not different. Both groups
had similar incidence of co-existing cardiovascular conditions
including hypertension, diabetes, and coronary artery disease. The
percentages of patients receiving treatment of ACEI, AT1RB, cal-
cium blocker or beta blocker were also similar between the two
groups (Table 2). Of note, there was no signiﬁcant difference in
ejection fraction between the AF and non-AF groups. Whereas
Table 1 | Primer sequences for RT-PCR.
Gene Sequence (5′→3′)
NOX1 Forward CAATCTCTCTCCTGGAATGGCATCCT
Reverse CCTGCTGCTCGGATATGAATGGAGAA
NOX2 Forward AAGGCTTCAGGTCCACAGAGGAAA
Reverse AGACTTTGTATGGACGGCCCAACT
NOX3 Forward ACCGTGGAGGAGGCAATTAGACAA
Reverse CAGGTTGAAGAAATGCGCCACGAT
NOX4 Forward AGCAGAGCCTCAGCATCTGTTCTT
Reverse TGGTTCTCCTGCTTGGAACCTTCT
NOX5 Forward CCTCCTCATGTTCATCTGCTCCAGTT
Reverse AGGAGGTAGGACAGGTGAGTCCAATA
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Table 2 | Patient characteristics.
Characteristic Non-AF AF pValue
Age 47.8±19.2 58.8±11.7 0.047
Gender (%male) 70% 61% 0.568
Hypertension 59% 39% 0.251
Diabetes 29% 28% 0.917
CAD 41% 33% 0.643
Family history of
heart disease
65% 44% 0.409
ACEI Therapy 53% 44% 0.627
AT1RBTherapy 29% 17% 0.384
Ca++ blocker
therapy
0% 11% 0.166
Beta blocker therapy 76% 55% 0.203
SBP (mmHg) 107.1±18.3 120.8±13.9 0.033
DBP (mmHg) 66.6±12.2 73.8±8.3 0.074
Ejection fraction (%
by ECHO)
20.82±2.3 22.67±2.5 0.586
TC (mg/dL) 158.6±33.6 158.0±44.1 0.967
TG (mg/dL) 137.8±57.2 144.5±53.6 0.266
CAD, coronary artery disease; ACEI, angiotensin converting enzyme inhibitor;
AT1RB, angiotensin II type-1 (AT1) receptor blocker; SBP, systolic blood pressure;
DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides.
diastolic blood pressure, total cholesterol and triglyceride levels
were not different in the AF vs. non-AF groups, systolic blood
pressure (SBP) was higher in the AF patients (Table 2). ACEI-
treated AF group had modestly higher SBP than those of non-AF
group receiving ACEI (Table 3).
REACTIVE OXYGEN SPECIES PRODUCTION
Among biologically relevant and abundant ROS, O•−2 , and H2O2
appear to be most important in redox signaling. Whereas O•−2
predominantly induces endothelial dysfunction by rapidly inac-
tivating nitric oxide (NO•), H2O2 inﬂuences different aspects of
endothelial cell function via complexmechanisms.Wehypothesize
that O•−2 and H2O2 also have differential roles in the regula-
tion of cardiac functions. Both species were quantitatively and
speciﬁcally determined by ESR and Amplex Red assay respec-
tively. Whereas total O•−2 production was not different between
AF and non-AF groups (Figure 1A), we found that H2O2 pro-
duction was more than doubled in AF patients compared to those
without (149.8± 26.28 vs. 66.9± 7.14 pmol/mg/min, p = 0.0055,
Figure 1B).
H2O2 PRODUCTION IN AF PATIENTS WITH CO-EXISTING
HYPERTENSION
Interestingly, AF patients with co-existing hypertension had
approximately 3-fold higher H2O2 production compared to those
without (239.0± 125.1 vs. 83.6± 51.3 pmol/mg/min, p = 0.003,
Table 4). Older AF patients (>50) also had higher tissue levels of
H2O2 compared to those younger AF patients (<50; 165± 118.8
vs. 95.0± 64.9 pmol/mg/min), although yet reaching statistical
signiﬁcance. In contrast, hypertension or age had no effect on
H2O2 levels in patients without AF (Table 4).
EXPRESSION OF DIFFERENT NOX ISOFORMS AND ITS RELATIONSHIP
TO H2O2
NOX4 is known to either produce H2O2 directly, or produce O
•−
2
in subcellular organelles leaving membrane permeable H2O2 the
sole detectable species (Martyn et al., 2006; Lambeth et al., 2007;
Serrander et al., 2007; Chen et al., 2008; Block et al., 2009; Lassegue
and Griendling, 2010). Other NOX isoforms however, have been
shown to produce O•−2 directly (Choi et al., 2008). Intriguingly,
NOX4 mRNA expression was found signiﬁcantly upregulated in
AF patients (Figure 2A), which correlated well with a marked
increase in H2O2 production (Figure 2B). The expression of
NOX1 and NOX2 however, was not different in patients with and
without AF (Figures 3A,B). NOX3 and NOX5 were not detectable
in LAA. We did not ﬁnd any correlation between ejection frac-
tions and NOX4/H2O2 levels in both groups. This indicates that
severity of heart failure is not linked to NOX4-H2O2 axis as AF
does.
NOX4 EXPRESSION AND H2O2 PRODUCTION IN ANG II-STIMULATED
HL-1 ATRIAL CELLS
In additional experiments, we examined whether Ang II activates
NOX4 in HL-1 atrial cells that have been well characterized to
maintain a differentiated, adult cardiomyocyte and atrial cell-like
phenotype. In our hand we have also been able to reproduce the
culture condition and observe the beating HL-1 cells following the
published Claycomb conditions. Of note, the Ang II receptor AT1
was abundantly expressed in these cells, and it was upregulated
by Ang II (Figures 4A,C). Ang II stimulation resulted in upreg-
ulation of NOX4 protein expression and an associated increase
in H2O2 production (Figures 4A,B,D). The NOX4mRNA expres-
sion,determinedby real-timeRT-PCR,was also foundupregulated
by Ang II in HL-1 cells (Figure 4E).
DISCUSSION
In the present study, we have discovered that NOX4-derived H2O2
production ismarkedly increased in the LAA tissues of AFpatients.
Hydrogen peroxide production in LAA was 3-fold higher in AF
patients with co-existing hypertension than those without. Hyper-
tension is an established risk factor for AF. Recent studies have
indicated that H2O2 regulates electrical properties of isolated rab-
bit pulmonary vein and atrial cells (Lin et al., 2010). Together
with the previously characterized role of H2O2 in myocardial
ﬁbrosis, these data suggest that NOX4-derived H2O2 may play
an important role in the development of AF. Indeed, in additional
studies utilizing HL-1 atrial cells, we found that Ang II stimulation
led to NOX4 upregulation and increased H2O2 production, fur-
ther implicating a potential role of NOX4-derived H2O2 in atrial
structural remodeling that is considered an important initiating
process of AF.
Aging and hypertension are the best-characterized, potential
causal factors for AF. Of signiﬁcant interest, we found that AF
patients with co-existing hypertension had 3-folds higher H2O2
production compared to those without AF. AF patients that are
older (>50) also had apparently higher H2O2 production. These
observations may further suggest that augmented local cardiac
production of H2O2 is involved in arrhythmogenesis, besides its
proinﬂammatory and prothrombotic effects. On the other hand,
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Table 3 | Blood pressure control in patient subgroups.
Characteristic ACEI Non-ACEI
Non-AF (n =7) AF (n =8) pValue Non-AF (n =8) AF (n =12) pValue
SBP 104.1±16.2 119.1±12.4 0.024 110.6±19.4 123±16.8 0.236
DBP 68.6±11.0 74.5±9.4 0.236 70.2±10.3 76.4±4.4 0.233
AT1RB Non-AT1RB
Non-AF (n =12) AF (n =4) pValue Non-AF (n =13) AF (n =6) pValue
SBP 120.8±16.6 131±26.9 0.530 101.7±14.3 119.1±11.9 0.003
DBP 75.1±5.2 78.5±3.5 0.444 67.8±11.4 74.3±7.9 0.120
FIGURE 1 | Superoxide and hydrogen peroxide production in
patients with and without atrial fibrillation. (A)Total superoxide
production. LAA were homogenated and subsequently analyzed for
superoxide production using ESR. (B) Hydrogen peroxide production.
LAA lysates were analyzed for hydrogen peroxide production using the
Amplex Red assay.
Table 4 | Hydrogen peroxide levels in patient subgroups.
Characteristic Non-AF AF
Absence Presence pValue Absence Presence P Value
Hypertension 58.1±25.7 (n=6) 71.7±31.4 (n=11) 0.379 83.6±51.3 (n=11) 239.0±125.1 (n=7) 0.003
Diabetes 77.4±33.7 (n=12) 51.8±12.5 (n=5) 0.076 151.8±122.7 (n=13) 144.8±87.3 (n=5) 0.909
CAD 55.6±13.9 (n=10) 71.6±33.3 (n=7) 0.321 155.0±123.8 (n=12) 139.4±91.6 (n=6) 0.789
Gender Male Female
0.828
Male Female
0.544
65.9±32.2 (n=13) 69.8±21.6 (n=4) 136.6±117.9 (n=11) 170.6±105.9 (n=7)
Age <50 >50
0.070
<50 >50
0.278
53.3±14.6 (n=8) 79.0±34.5 (n=9) 95.0±64.9 (n=4) 165.5±118.8 (n=14)
AF may have made SBP control more difﬁcult (ACEI-AF group
had higher SBP than ACEI-non-AF group), which is likely related
to the substantially higher H2O2 production in hypertensive AF
patients. Although H2O2 can mediate compensatory relaxation
under certain conditions such as in the apolipoprotein E deﬁcient
atherosclerotic mice (Landmesser et al., 2003), excessive H2O2 is
involved in vascular remodelingwhich could in turn result in stiffer
blood vessels to deteriorate hypertension.
We found that LAA O•−2 production was not different in
patients with and without AF. We also found that xanthine oxi-
dase derived O•−2 was not different between the two groups (data
not shown). Xanthine oxidase has been previously shown to play
an important role in cardiac O•−2 production in patients with
heart failure. However its role in AF patients has never been
previously tested. It is interesting to speculate whereas xanthine
oxidase and/or other NOX isoforms is more important for O•−2
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FIGURE 2 | Upregulation of NOX4 expression and its correlation with
hydrogen peroxide production in patients with atrial fibrillation. (A)
NOX4 mRNA expression. NOX4 mRNA expression was determined by
RT-PCR analysis and normalization to endogenous amplicon of GAPDH. (B)
Correlation between NOX4 mRNA expression and hydrogen peroxide
production.
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FIGURE 3 | Expression of different NOX isoforms in patients with and
without atrial fibrillation. (A) NOX1 mRNA expression. (B) NOX2 mRNA
expression. NOX1 or NOX2 mRNA expression was determined by RT-PCR
analysis and normalization to endogenous amplicon of GAPDH.
production in heart failure patients, NOX4-derived H2O2 pro-
duction is more important in the condition of AF. Of course, this
hypothesis needs to be further investigated using larger patient
population. Potential regulations of ROS scavenging enzymes such
as superoxide dismutases and glutathione peroxidases, under the
environment of NOX4-dependent H2O2 overproduction, would
also be interesting to be further investigated.
Our data revealed an innovative role of NOX4 in H2O2 pro-
duction in AF patients. Previously NOX1 and NOX4 were found
undetectable in RAA (Kim et al., 2005). In human LAA, however,
we were able to detect abundant NOX1,NOX2, and NOX4mRNA
expression. Only NOX4 mRNA expression was upregulated by
AF, which correlated well with overproduction of H2O2 in AF
patients. Accumulating evidence have characterized the relatively
newly recognizedNOX4 and its ROS-producing activity in various
cell types such as endothelial cells (Ago et al., 2004, 2005), vascu-
lar smooth muscle (Lassegue et al., 2001; Wingler et al., 2001;
Touyz et al., 2002), and kidney cells (Shiose et al., 2001; Wingler
et al., 2001; Chabrashvili et al., 2002). Functionally, NOX4 has
been implicated in cell differentiation (Clempus et al., 2007; Ismail
et al., 2009; Schroder et al., 2009; Xiao et al., 2009), cell cycle tran-
sition (Sturrock et al., 2007), transcriptional activation (Bonello
et al., 2007), andmyoﬁbroblast activation andﬁbrogenic responses
(Hecker et al., 2009). In the heart, NOX4 has been shown to be
involved in hypertrophy induced cardiac apoptosis andmitochon-
drial dysfunction (Ago et al., 2010), andpressure overload-induced
heart failure (Byrne et al., 2003; Kuroda et al., 2010). Our data add
to this rapidly growing knowledge of NOX4 functions, demon-
strating a potential role of NOX4 in enhancing H2O2 production
in patients withAF,whichmight be involved in the pathogenesis of
AF. Of note, recent studies have demonstrated an important role
of myocardial ﬁbrosis in AF (Everett and Olgin, 2007). Therefore,
H2O2 may also contribute to AF via augmentation of myocardial
ﬁbrosis as recently reported (Morita et al., 2009).
HL-1 cardiomyocytes, derived from atrial cardiac muscle
cells from the AT1 mouse atrial cardiomyocyte tumor lineage,
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FIGURE 4 | NOX4,AT1R expression and hydrogen peroxide production in
angiotensin II treated HL-1 atrial cells. (A) RepresentativeWestern blots of
NOX4 and AT1R expression in Ang II treated HL-1 cells. (B) Densitometic
grouped data of NOX4 expression in Ang II treated HL-1 cells. (C)
Densitometic grouped data of NOX4 expression in Ang II treated HL-1 cells.
(D) Hydrogen peroxide production in Ang II treated HL-1 cells. (E) NOX4
mRNA expression in Ang II treated HL-1 cells. Data are represented as
Mean±SEM (N=4, *p<0.05 vs. CTRL).
maintains the differentiated adult cardiomyocyte phenotype
(Claycomb et al., 1998). This cell has been proved to possess
the organized sarcomere, ion channels, functional receptors, and
intracellular signaling proteins so that it contracts spontaneously,
divides, generates action potential, and responds to agonists
(White et al., 2004). Therefore, HL-1 cardiomyocyte has been
established as the useful tool to study the cellular and molecular
mechanisms underlying cardiac pathophysiologies (Rodriguez-
Sinovas et al., 2005; Brady et al., 2006; Barba et al., 2009). In partic-
ular, expression of renin–angiotensin system components andAng
II regulation of L-type calcium channel have been characterized
in HL-1 cells (Tsai et al., 2007, 2008). Moreover, transcriptional
proﬁle regulated by rapid electrical stimulation in HL-1 cells was
similar to those from human AF (Mace et al., 2009). Therefore, we
employed HL-1 cells as the cellular model to investigate whether
NOX4 is modulated by Ang II, which has been shown to modulate
atrial remodeling and ﬁbrillation. We found AT1R was expressed
in HL-1 cells and further upregulated by Ang II treatment. Most
importantly, exposure of HL-1 cells to Ang II resulted in increased
NOX4 mRNA and protein expression, without affecting NOX1
and NOX2 mRNA levels. This was accompanied by a signiﬁcant
elevation in H2O2 production.
In summary, our data have uncovered a NOX4-mediated over-
production of H2O2 in patients with AF. AF patients with hyper-
tension had markedly higher LAA H2O2 levels compared to
those without AF. In addition, H2O2 has been recently reported
to regulate electrical properties of pulmonary vein and atrial
cells, where the initiation of ectopic beats is believed to occur
to induce AF. It is also known to promote myocardial ﬁbro-
sis. The modulator of atrial remodeling and ﬁbrosis, Ang II,
also signiﬁcantly upregulated NOX4 expression and H2O2 pro-
duction in atrial HL-1 cells. Taken together, these data suggest
that NOX4 may play an important role in the pathogenesis
of AF.
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